Ayala Pharmaceuticals Inc (ADXS)
0.6455
+0.04
(+7.40%)
USD |
OTCM |
Apr 17, 16:00
Ayala Pharmaceuticals Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -8.168M |
| September 30, 2022 | -9.335M |
| June 30, 2022 | -7.023M |
| March 31, 2022 | -9.984M |
| December 31, 2021 | -7.792M |
| September 30, 2021 | -9.369M |
| June 30, 2021 | -11.55M |
| March 31, 2021 | -9.649M |
| Date | Value |
|---|---|
| December 31, 2020 | -6.944M |
| September 30, 2020 | -8.903M |
| June 30, 2020 | -5.328M |
| March 31, 2020 | -6.411M |
| December 31, 2019 | -4.225M |
| September 30, 2019 | -5.152M |
| June 30, 2019 | -3.135M |
| March 31, 2019 | -3.768M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.55M
Minimum
Jun 2021
-3.135M
Maximum
Jun 2019
-7.531M
Average
-7.792M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | -3.553M |
| InspireMD Inc | -4.392M |
| BiomX Inc | -6.249M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -3.77M |